RecruitingNCT06067399

Relationship Between Red Cell Distribution Width (RDW) and HbA1C in Patients With Type 2 Diabetes Mellitus After Glycemic Control


Sponsor

New Valley University

Enrollment

250 participants

Start Date

Dec 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Diabetes mellitus (DM) is an epidemic disease, with approximately 463 million persons diagnosed with it. Of those, 90% are patients with type 2 DM (T2DM). Some estimates indicate that 700 million cases of DM will be reported in 2045. T2DM develops due to insulin resistance, leading to reduced insulin secretion. DM has a number of associated complications, such as nephropathy, neuropathy, and cardiovascular disease.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This observational study examines the relationship between a routine blood marker called RDW (red cell distribution width — a measure of how uniform red blood cells are in size) and HbA1c (a measure of long-term blood sugar control) in patients with poorly controlled type 2 diabetes. The goal is to understand whether RDW can serve as a useful indicator of diabetes management. **You may be eligible if...** - You have been diagnosed with type 2 diabetes - Your HbA1c is above 7% (meaning your diabetes is not well controlled) **You may NOT be eligible if...** - You have type 1 diabetes or secondary diabetes (caused by another condition) - You have anemia or low hemoglobin - You have recently had a blood transfusion - You are pregnant or have certain blood disorders like TTP or inflammatory bowel disease Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTGlycated hemoglobin (HbA1C)

Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )

DIAGNOSTIC_TESTRDW

Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )

DIAGNOSTIC_TESTLipid profile

Blood test will be done at time of recruitment (for 2 groups) , after 3 months and after 6 months (for group 1 )


Locations(1)

New Valley University- Faculty of Medicine

Al Khārjah, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06067399


Related Trials